Jun 12, 2023

Great Papers Coming Out Soon in CID Journal

Learn about the great papers that have recently been accepted for publication in the CID Journal. These papers cover topics such as antibiotic myths for the infectious diseases clinician, antimicrobial stewardship training, and maintaining the utility of COVID-19 pandemic severity surveillance.

MEDICAL_RESEARCH

Paul Sax

Harvard/Brigham Infectious Diseases doctor, writer, @CIDJournal editor, educator. Prefer baseball to football, pizza to sushi, dogs to cats, Beatles to Stones.

Member of Infectious Diseases

Some great papers coming out soon in @CIDJournal, all recently accepted for publication. https://t.co/cmqO4Dqrxt
1/x pic.twitter.com/9OAmHN8hV4
— Paul Sax (@PaulSaxMD) June 12, 2023
Antibiotic Myths for the Infectious Diseases Clinician

2/x
— Paul Sax (@PaulSaxMD) June 12, 2023
Skills, Not Just Knowledge: Infectious Diseases (ID) Fellows’ Recommendations Regarding Antimicrobial Stewardship Training

3/x
— Paul Sax (@PaulSaxMD) June 12, 2023
Expanded Multivariable Models to Assist Patient Selection for Long-Acting Cabotegravir+Rilpivirine Treatment: Clinical Utility of a Combination of Patient, Drug Concentration, and Viral Factors Associated With Virologic Failure

4/x
— Paul Sax (@PaulSaxMD) June 12, 2023
Superior accuracy of Aspergillus plasma cell-free DNA PCR over serum galactomannan for the diagnosis of invasive aspergillosis

5/x
— Paul Sax (@PaulSaxMD) June 12, 2023
Maintaining the Utility of COVID-19 Pandemic Severity Surveillance: Evaluation of Trends in Attributable Deaths and Development and Validation of a Measurement Tool

6/x
— Paul Sax (@PaulSaxMD) June 12, 2023
SARS-CoV-2 Antibody Replacement Therapy for Immunocompromised Patients

7/x
— Paul Sax (@PaulSaxMD) June 12, 2023
Risk Factors and Outcomes of Hematogenous Vertebral Osteomyelitis in Patients with Staphylococcus aureus Bacteremia

8/x
— Paul Sax (@PaulSaxMD) June 12, 2023
A phase 3 randomized, double-blind, comparator-controlled study to evaluate safety, tolerability and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, in allogeneic hematopoietic cell transplant recipients (PNEU-STEM)

9/x
— Paul Sax (@PaulSaxMD) June 12, 2023
Risk of tuberculosis disease in people with chronic kidney disease without kidney failure: A systematic review and meta-analysis

10/x
— Paul Sax (@PaulSaxMD) June 12, 2023
No immunological interference or safety concerns when adjuvanted recombinant zoster vaccine is coadministered with a COVID-19 mRNA-1273 booster vaccine in adults aged 50 years and older: A randomized trial

11/x
— Paul Sax (@PaulSaxMD) June 12, 2023
Global Differences in the Management of Staphylococcus aureus Bacteremia: No International Standard of Care

12/x
— Paul Sax (@PaulSaxMD) June 12, 2023
Oral Nirmatrelvir and Ritonavir for Covid-19 in Vaccinated, Non-Hospitalized Adults, Ages 18-50 Years

13/x
— Paul Sax (@PaulSaxMD) June 12, 2023
That's a wrap for this thread! Find the latest papers on CID's home page, on the left

fin.https://t.co/cmqO4Dqrxt
— Paul Sax (@PaulSaxMD) June 12, 2023